Biomolecules,
Год журнала:
2024,
Номер
14(7), С. 877 - 877
Опубликована: Июль 21, 2024
Transient
receptor
potential
(TRP)
melastatin
member
8
(TRPM8)
is
a
non-selective
cation
channel
that
can
be
activated
by
low
temperatures
(8–26
°C),
cooling
agents
(including
menthol
analogs
such
as
menthol,
icilin,
and
WS-12),
voltage,
extracellular
osmotic
pressure
changes.
TRPM8
expression
has
been
identified
in
the
digestive
system
several
research
teams,
demonstrating
its
significant
involvement
tissue
function
pathologies
of
system.
Specifically,
studies
have
implicated
various
physiological
pathological
processes
esophagus,
stomach,
colorectal
region,
liver,
pancreas.
This
paper
aims
to
comprehensively
outline
distinct
role
different
organs
system,
offering
insights
for
future
mechanistic
investigations
TRPM8.
Additionally,
it
presents
therapeutic
targets
treating
conditions
tract
inflammation,
tumors,
sensory
functional
disorders,
other
related
diseases.
Furthermore,
this
addresses
limitations
existing
highlights
prospects
associated
with
Biomolecules,
Год журнала:
2023,
Номер
13(10), С. 1557 - 1557
Опубликована: Окт. 22, 2023
Ion
channels
play
a
crucial
role
in
wide
range
of
biological
processes,
including
cell
cycle
regulation
and
cancer
progression.
In
particular,
the
transient
receptor
potential
(TRP)
family
has
emerged
as
promising
therapeutic
target
due
to
its
involvement
several
stages
development
dissemination.
TRP
are
expressed
large
variety
cells
tissues,
by
increasing
cation
intracellular
concentration,
they
monitor
mechanical,
thermal,
chemical
stimuli
under
physiological
pathological
conditions.
Some
members
superfamily,
namely
vanilloid
(TRPV),
canonical
(TRPC),
melastatin
(TRPM),
ankyrin
(TRPA),
have
been
investigated
different
types
cancer,
breast,
prostate,
lung,
colorectal
cancer.
involved
processes
such
proliferation,
migration,
invasion,
angiogenesis,
drug
resistance,
all
related
mechanistically
associated
with
signaling
pain.
Understanding
cellular
molecular
mechanisms
which
influence
provides
new
opportunities
for
targeted
strategies.
Selective
inhibitors
initial
scrutiny
experimental
animals
anti-cancer
agents.
In-depth
knowledge
these
their
regulatory
may
lead
strategies
treatment,
providing
perspectives
effective
therapies.
Biomedicines,
Год журнала:
2024,
Номер
12(4), С. 751 - 751
Опубликована: Март 28, 2024
Many
anti-cancer
drugs,
such
as
taxanes,
platinum
compounds,
vinca
alkaloids,
and
proteasome
inhibitors,
can
cause
chemotherapy-induced
peripheral
neuropathy
(CIPN).
CIPN
is
a
frequent
harmful
side
effect
that
affects
the
sensory,
motor,
autonomic
nerves,
leading
to
pain,
numbness,
tingling,
weakness,
reduced
quality
of
life.
The
causes
are
not
fully
known,
but
they
involve
direct
nerve
damage,
oxidative
stress,
inflammation,
DNA
microtubule
dysfunction,
altered
ion
channel
activity.
also
affected
by
genetic,
epigenetic,
environmental
factors
modulate
risk
intensity
damage.
Currently,
there
no
effective
treatments
or
prevention
methods
for
CIPN,
symptom
management
mostly
symptomatic
palliative.
Therefore,
high
demand
better
understanding
cellular
molecular
mechanisms
involved
in
well
development
new
biomarkers
therapeutic
targets.
This
review
gives
an
overview
current
knowledge
challenges
field
focusing
on
biological
underlying
this
disorder.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 719 - 719
Опубликована: Янв. 5, 2024
This
review
summarizes
the
current
understanding
of
role
transient
receptor
potential
melastatin-subfamily
member
7
(TRPM7)
channels
in
pathophysiology
neoplastic
diseases.
The
TRPM
family
represents
largest
and
most
diverse
group
TRP
superfamily.
Its
subtypes
are
expressed
virtually
all
human
organs
playing
a
central
(patho)physiological
events.
TRPM7
protein
(along
with
TRPM2
TRPM6)
is
unique
that
it
has
kinase
activity
addition
to
channel
function.
Numerous
studies
demonstrate
chanzyme
tumorigenesis
other
tumor
hallmarks
such
as
proliferation,
migration,
invasion
metastasis.
Here
we
provide
an
up-to-date
overview
about
possible
TRMP7
broad
range
malignancies
tumors
nervous
system,
head
neck
cancers,
malignant
neoplasms
upper
gastrointestinal
tract,
colorectal
carcinoma,
lung
cancer,
urinary
breast
female
reproductive
organs,
prostate
cancer
pathologies.
Experimental
data
show
increased
expression
and/or
function
observed
types.
Thus,
may
be
promising
target
therapy.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 5, 2025
Cannabinoids
relieve
pain,
nausea,
anorexia
and
anxiety,
improve
quality
of
life
in
several
cancer
patients.
The
immunotherapy
with
checkpoint
inhibitors
(ICIs),
although
very
successful
a
subset
patients,
is
accompanied
by
moderate
to
severe
immune-related
adverse
events
(ir-AE)
that
often
necessitate
its
discontinuation.
Because
their
role
symptomatic
relief,
cannabinoids
have
been
used
combination
immune
inhibitor
(ICI)
immunotherapy.
A
few
studies
strongly
suggest
the
use
medicinal
cannabis
patients
attenuates
many
ir-AE
associated
ICI
increase
tolerability.
However,
no
significant
beneficial
effects
on
overall
survival,
progression
free
survival
or
relapses
were
observed;
rather,
some
noted
concurrent
administration
clinical
benefits
latter.
cannabinoids'
well
documented
immunosuppressive
mediated
through
cannabinoid
recptor-2
(CB2),
we
propose
considering
this
receptor
as
an
inhibitory
per
se.
simultaneous
neutralization
CB2,
treatment,
may
lead
better
outcomes
receiving
In
regard,
such
cannabidiol
(CBD)
cannabigerol
(CBG),
little
agonism
for
be
therapeutic
choices.
Additional
strategies
e.g.,
monoacylglycerol
lipase
(MAGL)
degrade
endocannabinoids
lipogenesis
formation
lipid
bilayers
cells
also
explored.
Future
should
take
into
consideration
gut
microbiota,
CYP450
polymorphism
haplotypes,
cannabinoid-drug
interactions
genetic
somatic
variations
occurring
receptors
signaling
pathways
personalized
cannabis-based
therapies
ICIs.
This
rational
knowledge-based
regimens
tailored
individual
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Июнь 14, 2023
Cold
thermoreceptor
neurons
detect
temperature
drops
with
highly
sensitive
molecular
machinery
concentrated
in
their
peripheral
free
nerve
endings.
The
main
entity
responsible
for
cold
transduction
these
is
the
thermo-TRP
channel
TRPM8.
Cold,
cooling
compounds
such
as
menthol,
voltage,
and
osmolality
rises
activate
this
polymodal
ion
channel.
Dysregulation
of
TRPM8
activity
underlies
several
physiopathological
conditions,
including
painful
hypersensitivity
response
to
axonal
damage,
migraine,
dry-eye
disease,
overactive
bladder,
forms
cancer.
Although
could
be
an
attractive
target
treating
prevalent
diseases,
there
still
a
need
potent
specific
modulators
potentially
suitable
future
clinical
trials.
This
goal
requires
complete
understanding
determinants
underlying
activation
by
chemical
physical
agonists,
inhibition
antagonists,
modulatory
mechanisms
behind
its
function
guide
more
successful
treatment
strategies.
review
recapitulates
information
obtained
from
different
mutagenesis
approaches
that
have
allowed
identification
amino
acids
cavity
comprised
S1-S4
TRP
domains
determine
modulation
ligands.
In
addition,
we
summarize
studies
revealing
regions
within
N-
C-terminus
transmembrane
domain
contribute
cold-dependent
gating.
We
also
highlight
latest
milestone
field:
cryo-electron
microscopy
structures
TRPM8,
which
provided
better
comprehension
21
years
extensive
research
channel,
shedding
light
on
bases
modulation,
promoting
rational
design
novel
drugs
selectively
regulate
abnormal
under
pathophysiological
conditions.
Mutation Research/Reviews in Mutation Research,
Год журнала:
2024,
Номер
793, С. 108488 - 108488
Опубликована: Янв. 1, 2024
The
DNA
damage
response
(DDR)
is
a
complex
and
highly
regulated
cellular
process
that
detects
repairs
damage.
integrity
of
the
molecule
crucial
for
proper
functioning
survival
cells,
as
can
lead
to
mutations,
genomic
instability,
various
diseases,
including
cancer.
DDR
safeguards
genome
by
coordinating
series
signaling
events
repair
mechanisms
maintain
stability
prevent
propagation
damaged
daughter
cells.
study
an
ion
channels
in
context
promising
avenue
biomedical
research.
Lately,
it
has
been
reported
movement
ions
through
plays
role
physiological
processes,
nerve
signaling,
muscle
contraction,
cell
maintaining
membrane
potential.
Knowledge
regarding
involvement
could
support
refinement
our
approach
several
pathologies,
mainly
cancer,
perhaps
innovative
therapies.
In
this
review,
we
focused
on
channel's
possible
DDR.
We
present
analysis
DDR,
their
mechanisms,
outcomes.
By
addressing
these
areas,
aim
provide
comprehensive
perspective
potentially
guide
future
research
field.
It
worth
noting
interplay
between
multifaceted.
More
needed
fully
understand
underlying
potential
therapeutic
implications
interactions.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(3), С. 1229 - 1229
Опубликована: Янв. 30, 2025
The
burden
of
cancer
is
growing
in
almost
every
country.
Bone
metastases
significantly
affect
the
prognosis
and
lead
to
an
increase
mortality
morbidity.
management
cancer-induced
bone
pain
(CIBP)
still
shows
various
unmet
needs.
Opioid
use
burdened
by
a
number
possible
side
effects.
Moreover,
recent
progresses
treatment
increased
life
expectancy
patients,
even
those
with
metastatic
disease.
In
this
narrative
review,
we
reported
main
findings
regarding
TRP
channel
function
models.
cation
channels
play
key
role
different
functions
cells,
including
regulation
their
potential
for
metastasization,
are
involved
pathways
perception,
through
peripheral
central
Genetic
deletion
decreased
sensitivity
following
tumour
cell
inoculation.
Preclinical
data
suggest
modulators
some
channels,
such
as
TRPV1,
TRPA1,
TRPM7
TRPM8.
Clinical
results
scarce;
however,
physiological
modulating
remodelling
involvement
preclinical
models
have
garnered
interest
areas
research
last
few
years,
innovative
analgesic
strategies
that
may
overcome
long-term
effects
opioids.
Journal of Immunoassay and Immunochemistry,
Год журнала:
2025,
Номер
unknown, С. 1 - 17
Опубликована: Фев. 16, 2025
Participation
of
TRPM8
in
hepatocellular
carcinoma
(HCC)
development
was
not
precisely
declared.
CD47
mediates
immune
escape
and
macrophage
phagocytosis
tumors.
CDK4
oncogenesis.
Synergistic
implications
TRPM8,
CD47,
HCC
were
This
research
aims
to
demonstrate
the
expressions
CD47and
declare
correlations
significance.
Paraffin
blocks
from
101
hCC
82
adjacent
non-tumorous
liver
immunostained
using
antibodies.
showed
highly
significant
increased
than
control
tissue
(p
<
0.001)
for
all.
significantly
associated
with
poor
prognostic
criteria
as
high
tumor
grade,
advanced
stage,
microvascular
invasion,
necrosis.
There
a
association
between
cirrhotic
non-cirrhotic
regarding
positive
0.02)
0.045).
direct
relationships
each
immunohistochemical
antibody
other
two.
Prolonged
overall
survival
low
=
0.019).
In
conclusion,
may
regulate
synergistic
functions
oncogenesis
accomplish
unfavorable
might
share
cirrhosis.
could
be
therapeutic
targets
HCC.
Rapamycin
(sirolimus),
a
macrolide
compound
isolated
from
the
bacterium
Streptomyces
hygroscopicus
,
is
widely
used
as
oral
medication
for
prevention
of
transplant
rejection
and
treatment
lymphangioleiomyomatosis.
It
also
incorporated
in
coronary
stent
coatings
to
prevent
restenosis
topical
preparations
skin
disorders.
Rapamycin’s
vivo
activities
are
generally
ascribed
its
binding
protein
FKBP12,
leading
potent
inhibition
mechanistic
target
rapamycin
kinase
(mTOR)
by
FKBP12-rapamycin
complex.
The
specific
rapamycin-induced
interaction
between
domains
mTOR
FKBP12
frequently
employed
cell
biological
research,
rapid
chemically-induced
dimerization
strategies.
Here
we
show
that
activates
TRPM8,
cation
channel
expressed
sensory
nerve
endings
serves
primary
cold
sensor
mammals.
Using
combination
electrophysiology,
Saturation
Transfer
Triple-Difference
(STTD)
NMR
spectroscopy
molecular
docking-based
targeted
mutagenesis,
demonstrate
directly
binds
TRPM8.
We
identify
rapamycin-binding
site
groove
voltage
sensor-like
domain
pore
domain,
distinct
sites
cooling
agents
known
TRPM8
agonists
menthol
icilin.
Related
immunosuppressants
act
partial
agonists,
competing
with
same
site.
These
findings
novel
provide
new
insights
into
mechanisms
activation,
which
may
assist
development
therapies
targeting
this
ion
channel.
Moreover,
our
indicate
caution
needed
when
using
approaches
based
on
study
regulation.
Transient
receptor
potential
cation
channel
subfamily
M
member
8
(TRPM8)
is
a
nonselective
thermosensory
expressed
in
peripheral
nociceptor
terminals
where
it
transduces
cold
temperatures
and
cooling
agents
such
as
menthol.
TRPM8
dysfunction
has
been
involved
disabling
sensory
symptoms,
allodynia.
In
addition,
its
widespread
expression
signaled
this
pivotal
therapeutic
target
for
variety
of
diseases,
from
neuropathies
to
cancer.
Thus,
the
design
validation
antagonists
an
important
endeavor
biomedicine.
To
address
this,
we
used
multicomponent
Passerini
Ugi
reactions
novel
family
modulators
using
scaffold
adamantane
ring
that
exhibits
drug‐like
qualities.
These
green
chemistry
transformations
are
ideal
fast
synthesis
libraries
medium
complexity
with
minimal
or
no
generation
waste
by‐products.
We
report
identification
agonists
antagonists.
Among
them,
2‐((3S,5S,7S)‐adamantan‐1‐ylamino)‐2‐oxoethyl
[1,1′‐biphenyl]‐2‐carboxylate
(referred
compound
23
)
potent
selective
antagonist
reduces
TRPM8‐induced
neuronal
firing
primary
cultures.
Compound
10‐fold
higher
potency
human
(hTRPM8)
than
hTRPV1
hTRPA1
channels.
Notably,
local
administration
significantly
attenuated
oxaliplatin‐induced
allodynia
by
modulating
epidermal
endings.
α‐acyloxy
carboxamide
appears
promising
candidate
topically
intervene
on
TRPM8‐mediated
neuropathies.